Publication: The influence of the carrier molecule on amoxicillin recognition by specific IgE in patients with immediate hypersensitivity reactions to betalactams.
dc.contributor.author | Ariza, Adriana | |
dc.contributor.author | Mayorga, Cristobalina | |
dc.contributor.author | Salas, Maria | |
dc.contributor.author | Doña, Inmaculada | |
dc.contributor.author | Martin-Serrano, Angela | |
dc.contributor.author | Perez-Inestrosa, Ezequiel | |
dc.contributor.author | Perez-Sala, Dolores | |
dc.contributor.author | Guzman, Antonio E | |
dc.contributor.author | Montañez, Maria I | |
dc.contributor.author | Torres, Maria J | |
dc.contributor.funder | Institute of Health “Carlos III” of the Ministry of Economy and Competitiveness | |
dc.contributor.funder | European Regional Development Fund (ERDF) | |
dc.contributor.funder | Red de Reacciones Adversas a Alergenos y Farmacos | |
dc.contributor.funder | Andalusian Regional Ministry of Economy and Knowledge (gr | |
dc.contributor.funder | Andalusian Regional Ministry Health | |
dc.date.accessioned | 2023-01-25T08:37:54Z | |
dc.date.available | 2023-01-25T08:37:54Z | |
dc.date.issued | 2016-10-12 | |
dc.description.abstract | The optimal recognition of penicillin determinants, including amoxicillin (AX), by specific IgE antibodies is widely believed to require covalent binding to a carrier molecule. The nature of the carrier and its contribution to the antigenic determinant is not well known. Here we aimed to evaluate the specific-IgE recognition of different AX-derived structures. We studied patients with immediate hypersensitivity reactions to AX, classified as selective or cross-reactors to penicillins. Competitive immunoassays were performed using AX itself, amoxicilloic acid, AX bound to butylamine (AXO-BA) or to human serum albumin (AXO-HSA) in the fluid phase, as inhibitors, and amoxicilloyl-poli-L-lysine (AXO-PLL) in the solid-phase. Two distinct patterns of AX recognition by IgE were found: Group A showed a higher recognition of AX itself and AX-modified components of low molecular weights, whilst Group B showed similar recognition of both unconjugated and conjugated AX. Amoxicilloic acid was poorly recognized in both groups, which reinforces the need for AX conjugation to a carrier for optimal recognition. Remarkably, IgE recognition in Group A (selective responders to AX) is influenced by the mode of binding and/or the nature of the carrier; whereas IgE in Group B (cross-responders to penicillins) recognizes AX independently of the nature of the carrier. | |
dc.description.sponsorship | The present study has been supported by Institute of Health “Carlos III” of the Ministry of Economy and Competitiveness (grants cofunded by European Regional Development Fund (ERDF): PI12/02529, PI15/01206, CP15/00103, Red de Reacciones Adversas a Alergenos y Farmacos RD12/0013/0001, RD12/0013/0003 and RD12/0013/0008, RD09/0076/00112 for the Biobank network and PT13/0010/0006 for the Biobank platform) and by State Secretariat for Research, Development and Innovation of the Ministry of Economy and Competitiveness (grants cofunded by European Regional Development Fund (ERDF): MINECO SAF2012-36519, SAF2015-68590-R/ FEDER and CTQ2013-41339-P). Andalusian Regional Ministry of Economy and Knowledge (grants cofunded by European Regional Development Fund (ERDF): CTS-06603); Andalusian Regional Ministry Health (grants: PI-0699-2011, PI-0159-2013 and PI-0179-2014) and Merck-Serono Research Grant from Fundación Salud 2000. CM holds a ‘Nicolas Monardes’ research contract by Andalusian Regional Ministry Health: C-0044-2012 SAS 2013. MIM holds a ‘Miguel Servet I’ research contract by Institute of Health “Carlos III” of the Ministry of Economy and Competitiveness (grants cofunded by European Social Fund (ESF)): CP15/00103. AA thanks “pFIS fellowship” (FI08/00385) from ISCIII and Andalucia “Talent Hub Fellowship” (TAHUB/II-004) cofunded by the Junta de Andalucia and the European Union, VII Framework Programme of the European Commission (grant agreement No. 291780). | |
dc.description.version | Si | |
dc.identifier.citation | Ariza A, Mayorga C, Salas M, Doña I, Martín-Serrano Á, Pérez-Inestrosa E, et al. The influence of the carrier molecule on amoxicillin recognition by specific IgE in patients with immediate hypersensitivity reactions to betalactams. Sci Rep. 2016 Oct 12;6:35113 | |
dc.identifier.doi | 10.1038/srep35113 | |
dc.identifier.essn | 2045-2322 | |
dc.identifier.pmc | PMC5059705 | |
dc.identifier.pmid | 27731424 | |
dc.identifier.pubmedURL | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5059705/pdf | |
dc.identifier.unpaywallURL | https://www.nature.com/articles/srep35113.pdf | |
dc.identifier.uri | http://hdl.handle.net/10668/10528 | |
dc.journal.title | Scientific reports | |
dc.journal.titleabbreviation | Sci Rep | |
dc.language.iso | en | |
dc.organization | Centro Andaluz de Nanomedicina y Biotecnología-BIONAND | |
dc.organization | Instituto de Investigación Biomédica de Málaga-IBIMA | |
dc.organization | Hospital Universitario Regional de Málaga | |
dc.page.number | 10 | |
dc.provenance | Realizada la curación de contenido 16/05/2025 | |
dc.publisher | Nature Publishing Group | |
dc.pubmedtype | Journal Article | |
dc.pubmedtype | Research Support, Non-U.S. Gov't | |
dc.relation.projectID | PI12/02529 | |
dc.relation.projectID | PI15/01206 | |
dc.relation.projectID | RD12/0013/0001 | |
dc.relation.projectID | SAF2012-36519 | |
dc.relation.projectID | CTQ2013-41339-P | |
dc.relation.projectID | PI-0699-2011 | |
dc.relation.projectID | PI-0159-2013 | |
dc.relation.publisherversion | https://doi.org/10.1038/srep35113 | |
dc.rights | Attribution 4.0 International | |
dc.rights.accessRights | open access | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.subject | Amoxicillin | |
dc.subject | Anaphylaxis | |
dc.subject | Antibody Specificity | |
dc.subject | Butylamines | |
dc.subject | Carrier Proteins | |
dc.subject | Cross Reactions | |
dc.subject.decs | Inmunoglobulina E | |
dc.subject.decs | Penicilinas | |
dc.subject.decs | Amoxicilina | |
dc.subject.decs | Inmunoensayo | |
dc.subject.decs | Hipersensibilidad inmediata | |
dc.subject.decs | Albúmina sérica humana | |
dc.subject.mesh | Adult | |
dc.subject.mesh | Aged | |
dc.subject.mesh | Drug Hypersensitivity | |
dc.subject.mesh | Female | |
dc.subject.mesh | Haptens | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Hypersensitivity, Immediate | |
dc.subject.mesh | Immunoglobulin E | |
dc.subject.mesh | Male | |
dc.subject.mesh | Middle Aged | |
dc.subject.mesh | Penicillins | |
dc.subject.mesh | Polylysine | |
dc.subject.mesh | Serum Albumin, Human | |
dc.subject.mesh | Urticaria | |
dc.subject.mesh | Young Adult | |
dc.subject.mesh | beta-Lactams | |
dc.title | The influence of the carrier molecule on amoxicillin recognition by specific IgE in patients with immediate hypersensitivity reactions to betalactams. | |
dc.type | research article | |
dc.type.hasVersion | VoR | |
dc.volume.number | 6 | |
dspace.entity.type | Publication |